News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
839,891 Results
Type
Article (86045)
Company Profile (651)
Press Release (753195)
Section
Business (232472)
Career Advice (4123)
Deals (39703)
Drug Delivery (127)
Drug Development (90838)
Employer Resources (195)
FDA (18029)
Job Trends (17303)
News (395980)
Policy (39666)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2982)
Academic (1)
Accelerated approval (3)
Adcomms (26)
Allergies (83)
Alliances (56712)
ALS (83)
Alzheimer's disease (1431)
Antibody-drug conjugate (ADC) (123)
Approvals (17993)
Artificial intelligence (248)
Autoimmune disease (13)
Automation (14)
Bankruptcy (399)
Best Places to Work (12616)
BIOSECURE Act (21)
Biosimilars (104)
Biotechnology (448)
Bladder cancer (54)
Brain cancer (26)
Breast cancer (242)
Cancer (1890)
Cardiovascular disease (154)
Career advice (3524)
Career pathing (32)
CAR-T (147)
Cell therapy (418)
Cervical cancer (14)
Clinical research (72699)
Collaboration (752)
Compensation (400)
Complete response letters (27)
COVID-19 (2839)
CRISPR (38)
C-suite (193)
Cystic fibrosis (103)
Data (1751)
Decentralized trials (2)
Denatured (41)
Depression (43)
Diabetes (231)
Diagnostics (6833)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (114)
Drug pricing (114)
Drug shortages (28)
Duchenne muscular dystrophy (69)
Earnings (95627)
Editorial (32)
Employer branding (25)
Employer resources (166)
Events (128573)
Executive appointments (612)
FDA (19035)
Featured Employer (69)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (667)
Gene editing (98)
Generative AI (25)
Gene therapy (297)
GLP-1 (773)
Government (5091)
Grass and pollen (4)
Guidances (46)
Healthcare (20833)
Huntington's disease (24)
IgA nephropathy (22)
Immunology and inflammation (104)
Indications (24)
Infectious disease (2963)
Inflammatory bowel disease (140)
Inflation Reduction Act (11)
Influenza (45)
Intellectual property (73)
Interviews (811)
IPO (17773)
IRA (48)
Job creations (5183)
Job search strategy (2860)
Kidney cancer (10)
Labor market (30)
Layoffs (521)
Leadership (19)
Legal (10081)
Liver cancer (74)
Lung cancer (274)
Lymphoma (123)
Machine learning (2)
Management (64)
Manufacturing (275)
MASH (61)
Medical device (14511)
Medtech (14516)
Mergers & acquisitions (22308)
Metabolic disorders (643)
Multiple sclerosis (64)
NASH (23)
Neurodegenerative disease (85)
Neuropsychiatric disorders (29)
Neuroscience (1904)
NextGen: Class of 2025 (7664)
Non-profit (5075)
Northern California (2259)
Now hiring (36)
Obesity (353)
Opinion (263)
Ovarian cancer (64)
Pain (77)
Pancreatic cancer (72)
Parkinson's disease (124)
Partnered (19)
Patents (189)
Patient recruitment (83)
Peanut (50)
People (64840)
Pharmaceutical (133)
Pharmacy benefit managers (21)
Phase I (22432)
Phase II (31579)
Phase III (23773)
Pipeline (835)
Podcasts (115)
Policy (122)
Postmarket research (3551)
Preclinical (10056)
Press Release (72)
Prostate cancer (86)
Psychedelics (37)
Radiopharmaceuticals (262)
Rare diseases (368)
Real estate (7381)
Recruiting (74)
Regulatory (26447)
Reports (54)
Research institute (2647)
Resumes & cover letters (649)
Rett syndrome (2)
RNA editing (1)
RSV (38)
Schizophrenia (68)
Series A (124)
Series B (73)
Service/supplier (27)
Sickle cell disease (55)
Southern California (1935)
Special edition (17)
Sponsored (33)
Startups (4284)
State (2)
Stomach cancer (12)
Supply chain (58)
The Weekly (73)
United States (20564)
Vaccines (727)
Venture capitalists (35)
Webinars (13)
Weight loss (264)
Women's health (35)
Worklife (16)
Date
Today (175)
Last 7 days (794)
Last 30 days (3107)
Last 365 days (36493)
2025 (6014)
2024 (37555)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1269)
Alabama (55)
Alaska (7)
Arizona (246)
Arkansas (13)
Asia (49800)
Australia (8782)
California (5255)
Canada (1788)
China (441)
Colorado (241)
Connecticut (252)
Delaware (119)
Europe (114068)
Florida (760)
Georgia (180)
Hawaii (1)
Idaho (64)
Illinois (534)
India (23)
Indiana (288)
Iowa (8)
Japan (129)
Kansas (106)
Kentucky (25)
Louisiana (10)
Maine (64)
Maryland (833)
Massachusetts (4104)
Michigan (214)
Minnesota (370)
Mississippi (2)
Missouri (73)
Montana (30)
Nebraska (26)
Nevada (56)
New Hampshire (64)
New Jersey (1492)
New Mexico (29)
New York (1488)
North Carolina (1012)
North Dakota (8)
Northern California (2259)
Ohio (184)
Oklahoma (14)
Oregon (44)
Pennsylvania (1175)
Puerto Rico (7)
Rhode Island (25)
South America (1649)
South Carolina (13)
South Dakota (1)
Southern California (1935)
Tennessee (84)
Texas (773)
Utah (159)
Virginia (129)
Washington D.C. (60)
Washington State (517)
West Virginia (3)
Wisconsin (47)
839,891 Results for "tevogen bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations
March 3, 2025
·
6 min read
Press Releases
Tevogen Bio’s Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
February 11, 2025
·
5 min read
Press Releases
Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical Countermeasure
February 9, 2025
·
2 min read
Press Releases
Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding
January 28, 2025
·
6 min read
Press Releases
Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy
March 3, 2025
·
5 min read
Press Releases
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
January 24, 2025
·
7 min read
Pharm Country
Tevogen Bio Set to Join Russell 3000® Index
Tevogen Bio Holdings Inc. is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, according to a preliminary list of additions posted Friday, May 24.
June 12, 2024
·
4 min read
Business
Tevogen Bio Reports First Quarter 2024 Financial Results
Tevogen Bio Holdings Inc. has announced financial results for the fiscal quarter ended March 31, 2024, and filed its quarterly report on Form 10-Q with the Securities and Exchange Commission.
May 29, 2024
·
7 min read
Pharm Country
Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGN
Tevogen Bio Holdings Inc. has announced the completion of Tevogen Bio Inc’s previously announced business combination with Semper Paratus Acquisition Corporation, leading to the formation of Tevogen Bio Holdings Inc.
February 14, 2024
·
7 min read
Pharm Country
Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
Tevogen Bio Holdings Inc. has entered into a binding term sheet [with an existing investor] to secure up to $50 million of financing.
May 10, 2024
·
6 min read
1 of 83,990
Next
